Results 181 to 190 of about 38,450 (324)

Epidemiological approaches to evaluate clinical unmasking of HPV‐associated cervical lesions in the HPV vaccination era

open access: yesInternational Journal of Cancer, EarlyView.
Abstract HPV vaccination reduces the risk of developing HPV‐attributable cancers, including cervical cancer. However, an attenuation of HPV vaccine impact after the implementation of HPV vaccination may occur through clinical unmasking. Clinical unmasking is a distinct and complex phenomenon that arises in the absence of clinical interventions ...
Joseph E. Tota   +8 more
wiley   +1 more source

Pioneering robotic surgery for complex gynecologic conditions: implementation beyond cancer care. [PDF]

open access: yesJ Robot Surg
Hernández A   +12 more
europepmc   +1 more source

Anti‐Her2 therapy patterns in metastatic breast cancer—Real‐world data suggest undertreatment

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Although human epidermal growth factor 2‐positive (HER2+) breast cancer is an aggressive malignancy, significant survival benefits are possible with targeted anti‐HER2 therapies. Whether these therapies are used as recommended, however, is unknown. Here, the authors investigated data from population‐based registries in Norway to assess anti‐
Kathrine F. Vandraas   +9 more
wiley   +1 more source

Long‐term human papillomavirus genotype‐specific risk of cervical high‐grade intraepithelial lesion and cancer—By age group and triage cytology

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Human papillomavirus (HPV) testing has revolutionized cervical cancer screening. Nonetheless, its optimal use for distinguishing between high‐ and low‐risk infections to leverage screening benefits remains to be established. Here, long‐term HPV genotype‐specific risk of precancerous cervical intraepithelial neoplasia grade 2 or higher was ...
Maija Vahteristo   +6 more
wiley   +1 more source

Trends in cervical cancer incidence in the Netherlands: A join‐point and age–period–cohort analysis (1989–2023)

open access: yesInternational Journal of Cancer, EarlyView.
What's New? This ecological study of trends in cervical cancer incidence from 1989 to 2023 in the Netherlands indicates a positive impact of screening, with a steady decline over the years. However, incidence increased from 2003 to 2023, particularly among younger cohorts, aligning with reduced participation and the introduction of more sensitive, high‐
Kelly Melisa Castañeda   +5 more
wiley   +1 more source

Evaluation of targeted next‐generation sequencing for detection of HPV genotypes and sublineages in cervical liquid‐based cytology SurePath samples from the Danish screening program

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Human papillomavirus (HPV) assays currently used in cervical cancer screening detect genotypes without providing information on viral lineages and sublineages. However, genotype‐specific sublineages may have distinct risk profiles, which could be harnessed to further improve risk stratification.
Karoline Andersen   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy